The incidence of anti-TPO positivity seen earlier than the onset of subclinical/overt hyperthyroidism was significantly higher (p<0.0001) than the combined control group and the anti-TPO was positive in an average of 277 (±151) days ahead of the onset of subclinical/overt hyperthyroidism. The gene discussed is TPO; the disease is hyperthyroidism.